Effectiveness of bisphosphonate therapy in a community setting-Reference-Cited by-同舟云学术

Effectiveness of bisphosphonate therapy in a community setting

Published:2009-01 Issue:1 Volume:44 Page:153-159
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Feldstein Adrianne C.,Weycker Derek,Nichols Gregory A.,Oster Gerry,Rosales Gabriela,Boardman David L.,Perrin Nancy

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference37 articles.

1. Epidemiology and outcomes of osteoporotic fractures;Cummings;Lancet,2002

2. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025;Burge;J. Bone Miner. Res.,2007

3. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 1. Introduction;Hanley;CMAJ,1996

4. Fracture prevention in postmenopausal osteoporosis: a review of treatment options;McCarus;Obstet. Gynecol. Surv.,2006

5. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group;Black;Lancet,1996

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pterostilbene-isothiocyanate impedes RANK/TRAF6 interaction to inhibit osteoclastogenesis, promoting osteogenesis in vitro and alleviating glucocorticoid induced osteoporosis in rats;Biochemical Pharmacology;2022-12

2. Comparing the efficacies of bisphosphonates’ therapies for osteoporosis persistence and compliance: A Systematic Review;Current Molecular Medicine;2021-04-14

3. Real-world effectiveness of osteoporosis treatment in the oldest old;Osteoporosis International;2020-03-30

4. Overestimation of the Limitations of Randomized Controlled Trials;Journal of Bone and Mineral Research;2019-07-11

5. Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review;BMJ Open;2019-04